Prognostic factors in stage IB gastric cancer

被引：0

作者：

Toru Aoyama ^{[1
]}

Takaki Yoshikawa ^{[1
]}

Hirohito Fujikawa ^{[1
]}

Tsutomu Hayashi ^{[1
]}

Takashi Ogata ^{[1
]}

Haruhiko Cho ^{[1
]}

Takanobu Yamada ^{[2
]}

Shinichi Hasegawa ^{[2
]}

Kazuhito Tsuchida ^{[2
]}

Norio Yukawa ^{[2
]}

Takashi Oshima ^{[2
]}

Mari S Oba ^{[3
]}

Satoshi Morita ^{[3
]}

Yasushi Rino ^{[2
]}

Munetaka Masuda ^{[2
]}

机构：

[1] Department of Gastrointestinal Surgery, Kanagawa Cancer Center,Yokohama 241-0815,Japan

[2] Department of Surgery,Yokohama City University,Yokohama 236-0004,Japan

[3] Department of Biostatistics and Epidemiology,Yokohama City University,Yokohama 236-0004,Japan

来源：

World Journal of Gastroenterology | 2014年 / 21期

关键词：

Gastric cancer; Stage IB; Prognostic factor;

D O I：

暂无

中图分类号：

R735.2 [胃肿瘤];

学科分类号：

100214 ;

摘要：

AIM:To identify the subset of patients with stage IB gastric cancer with an unfavorable prognosis.METHODS:Overall survival(OS)rates were examined in 103 patients with stage IB(T1N1M0 and T2N0M0)gastric cancer between January 2000 and December2011.Univariate and multivariate analyses were performed to identify risk factors using a Cox proportional hazards model.RESULTS:The OS rates of patients with T1N1 and T2N0 cancer were 89.2%and 94.1%at 5-years,re-spectively.Both univariate and multivariate analyses demonstrated that tumor location was the only significant prognostic factor.The OS rate was 81.8%at5-years when the tumor was located in the upper third of the stomach and was 95.5%at 5-years when the tumor was located in the middle or lower third of the stomach(P=0.0093).CONCLUSION:These data may suggest that tumor location is associated with survival in patients with stage IB gastric cancer.

引用

页码：6580 / 6585

页数：6

共 9 条

[1] Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy [J].

Aoyama, Toru ;

Yoshikawa, Takaki ;

Hayashi, Tsutomu ;

Kuwabara, Hiroshi ;

Mikayama, Yo ;

Ogata, Takashi ;

Cho, Haruhiko ;

Tsuburaya, Akira .

ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) :1568-1574

[2] Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery [J].

Yamada, Takanobu ;

Hayashi, Tsutomu ;

Cho, Haruhiko ;

Yoshikawa, Takaki ;

Taniguchi, Hideki ;

Fukushima, Ryoji ;

Tsuburaya, Akira .

GASTRIC CANCER, 2012, 15 (01) :34-41

[3] Clinicopathological analysis for recurrence of stage Ib gastric cancer (according to the second English edition of the Japanese classification of gastric carcinoma) [J].

Yokoyama, Takashi ;

Kamada, Kiyoshi ;

Tsurui, Yoshikazu ;

Kashizuka, Hisanori ;

Okano, Eiji ;

Ogawa, Sanehito ;

Obara, Shinsaku ;

Tatsumi, Mitsutoshi .

GASTRIC CANCER, 2011, 14 (04) :372-377

[4] Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1 [J].

Aoyama, Toru ;

Yoshikawa, Takaki ;

Watanabe, Takafumi ;

Hayashi, Tsutomu ;

Ogata, Takashi ;

Cho, Haruhiko ;

Tsuburaya, Akira .

GASTRIC CANCER, 2011, 14 (03) :274-278

[5] Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of Gastric Adenocarcinoma in Comparison With the Sixth Classification [J].

Ahn, Hye Seong ;

Lee, Hyuk Joon ;

Hahn, Seokyung ;

Kim, Woo Ho ;

Lee, Kuhn Uk ;

Sano, Takeshi ;

Edge, Stephen B. ;

Yang, Han-Kwang .

CANCER, 2010, 116 (24) :5592-5598

[6]

Narikazu Boku,Seiichiro Yamamoto,Haruhiko Fukuda,Kuniaki Shirao,Toshihiko Doi,Akira Sawaki,Wasaburo Koizumi,Hiroshi Saito,Kensei Yamaguchi,Hiroya Takiuchi,Junichiro Nasu,Atsushi Ohtsu.Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study[J].Lancet Oncology,2009(11)

[7] Recurrence in early gastric cancer with lymph node metastasis [J].

Saka, Makoto ;

Katai, Hitoshi ;

Fukagawa, Takeo ;

Nijjar, Rajwinder ;

Sano, Takeshi .

GASTRIC CANCER, 2008, 11 (04) :214-218

[8]

Wasaburo Koizumi,Hiroyuki Narahara,Takuo Hara,Akinori Takagane,Toshikazu Akiya,Masakazu Takagi,Kosei Miyashita,Takashi Nishizaki,Osamu Kobayashi,Wataru Takiyama,Yasushi Toh,Takashi Nagaie,Seiichi Takagi,Yoshitaka Yamamura,Kimihiko Yanaoka,Hiroyuki Orita,Masahiro Takeuchi.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial[J].Lancet Oncology,2008(3)

[9] Proximal versus distal gastric carcinoma - What are the differences? [J].

Piso, P ;

Werner, U ;

Lang, H ;

Mirena, P ;

Klempnauer, J .

ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (07) :520-525

← 1 →